Sputnik V, we have a problem ...

Scientists query the Lancet's publication of Russian vaccine trial data

Some 15 scientists have written to The Lancet questioning the journal’s publication of trial results for Russia’s COVID-19 vaccine, saying the similarities in patient data were improbable.

The Lancet published the results of a combined phase 1-2 trial early this month, several weeks after Russian President Vladimir Putin declared his country was the first to approve a vaccine against the virus.

The vaccine, dubbed Sputnik V and developed by the Gamaleya Research Institute of Epidemiology and Microbiology